Parkside Financial Bank & Trust increased its position in shares of MetLife, Inc. (NYSE:MET) by 14.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,490 shares of the financial services provider’s stock after purchasing an additional 1,098 shares during the period. Parkside Financial Bank & Trust’s holdings in MetLife were worth $441,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Farmers National Bank purchased a new position in MetLife during the second quarter worth about $118,000. Westside Investment Management Inc. raised its holdings in MetLife by 583.8% during the first quarter. Westside Investment Management Inc. now owns 2,694 shares of the financial services provider’s stock worth $140,000 after purchasing an additional 2,300 shares in the last quarter. Parallel Advisors LLC raised its holdings in MetLife by 50.7% during the first quarter. Parallel Advisors LLC now owns 2,748 shares of the financial services provider’s stock worth $143,000 after purchasing an additional 924 shares in the last quarter. First Mercantile Trust Co. raised its holdings in MetLife by 3.4% during the second quarter. First Mercantile Trust Co. now owns 2,926 shares of the financial services provider’s stock worth $161,000 after purchasing an additional 97 shares in the last quarter. Finally, Carroll Financial Associates Inc. raised its holdings in MetLife by 5.8% during the second quarter. Carroll Financial Associates Inc. now owns 3,013 shares of the financial services provider’s stock worth $165,000 after purchasing an additional 166 shares in the last quarter. 73.91% of the stock is owned by hedge funds and other institutional investors.
MetLife, Inc. (NYSE MET) traded up 0.30% during mid-day trading on Tuesday, hitting $54.13. 756,388 shares of the stock traded hands. The stock has a 50 day moving average price of $51.78 and a 200 day moving average price of $48.45. The firm has a market cap of $57.53 billion, a PE ratio of 636.82 and a beta of 1.47. MetLife, Inc. has a 12-month low of $40.53 and a 12-month high of $54.39.
MetLife (NYSE:MET) last released its quarterly earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The company had revenue of $17.39 billion for the quarter, compared to the consensus estimate of $17.11 billion. During the same period in the previous year, the firm earned $0.83 EPS. MetLife’s revenue was up 2.5% on a year-over-year basis. On average, analysts expect that MetLife, Inc. will post $4.77 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 13th. Investors of record on Monday, November 6th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, November 3rd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.96%. MetLife’s payout ratio is currently 1,777.98%.
Several research firms recently issued reports on MET. Goldman Sachs Group, Inc. (The) began coverage on shares of MetLife in a report on Wednesday, October 18th. They set a “conviction-buy” rating and a $61.00 price target for the company. Langen Mcalenn reissued a “buy” rating on shares of MetLife in a report on Wednesday, August 16th. Wells Fargo & Company reissued a “buy” rating on shares of MetLife in a report on Monday, August 7th. BidaskClub raised shares of MetLife from a “sell” rating to a “hold” rating in a report on Wednesday, August 9th. Finally, Zacks Investment Research cut shares of MetLife from a “hold” rating to a “sell” rating in a report on Wednesday, August 9th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $57.62.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The correct version of this piece of content can be viewed at https://www.com-unik.info/2017/10/31/parkside-financial-bank-trust-has-441000-position-in-metlife-inc-met.html.
MetLife Company Profile
MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.
What are top analysts saying about MetLife Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for MetLife Inc. and related companies.